Takeda Announces Approval of First Oral Therapy for Eosinophilic Esophagitis.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Works matching DE "TAKEDA (Company)"
Results: 3
1
2
Integrin inhibitors go with the gut.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 411, doi. 10.1038/nrd4037
- By:
- Publication type:
- Article
3
Deal watch: Intra-Cellular Therapies and Takeda to develop PDE1 inhibitors for schizophrenia.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 5, p. 329, doi. 10.1038/nrd3438
- Publication type:
- Article